Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Oncotarget|August 6, 2016
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancersHow-Wen Ko, Heng-Huan Lee, Longfei Huo, et al.International Journal of Dermatology|September 25, 2020
Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort studyChun-Wei Lu, Ting-Ya Wang, Chi-Feng Yen, et al.Cancer Cell|June 15, 2013
Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancersTzu-Hsuan Huang, Longfei Huo, Ying-Nai Wang, et al.Cancer Research|October 21, 2016
Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated MethylationYan Wang, Jung-Mao Hsu, Ya'an Kang, et al.Nature Communications|November 10, 2019
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Yongkun Wei, Fei Zhang, et al.Nature Communications|January 31, 2020
Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Yongkun Wei, Fei Zhang, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|November 11, 2022
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinomaChun-Wei Lu, Jong-Hwei Su Pang, Yu-Shien Ko, et al.Cancer Research|January 14, 2016
AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 DegradationChia-Wei Li, Weiya Xia, Seung-Oe Lim, et al.American Journal of Cancer Research|May 11, 2023
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cellsLei Nie, Ying-Nai Wang, Jung-Mao Hsu, et al.Therapeutic Advances in Medical Oncology|June 7, 2021
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 studyYen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, et al.Pageof 5